The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS

Hepatic encephalopathy (HE) is the major complication of transjugular intrahepatic portosystemic shunt (TIPS). In cirrhotic patients, a correlation between sarcopenia and HE has been suggested.

• Publication year

  2019

• Venue

  Liver international (Print)

• Publication date

  2019-02-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/liv.14050PMID 30667572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis

  2018cited by this paper
• Fat‐free muscle mass in magnetic resonance imaging predicts acute‐on‐chronic liver failure and survival in decompensated cirrhosis

  2018cited by this paper
• A multicenter study to define sarcopenia in patients with end‐stage liver disease

  2017cited by this paper
• Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement

  2017cited by this paper
• Hyperammonaemia‐induced skeletal muscle mitochondrial dysfunction results in cataplerosis and oxidative stress

  2016cited by this paper
• Metabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of l-leucine in cirrhosis.

  2016cited by this paper
• Cause and management of muscle wasting in chronic liver disease

  2016cited by this paper
• The Role of Sarcopenia and Frailty in Hepatic Encephalopathy Management.

  2015cited by this paper
• Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis

  2015cited by this paper
• Amino acids and autophagy: cross-talk and co-operation to control cellular homeostasis

  2015cited by this paper
• A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis.

  2015cited by this paper
• Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

  2014cited by this paper
• Improvement in the nutritional status and clinical conditions of patients with liver failure using a liver diet combined with a branched chain amino acids-enriched elemental diet.

  2014cited by this paper
• TIPS: 25 years later.

  2013cited by this paper
• Myostatin/activin pathway antagonism: molecular basis and therapeutic potential.

  2013cited by this paper
• Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent

  2013cited by this paper
• Muscle mass predicts outcomes following liver transplantation

  2013cited by this paper
• Muscle wasting is associated with mortality in patients with cirrhosis.

  2012cited by this paper
• Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

  2012cited by this paper
• Nutritional support for liver disease.

  2012cited by this paper
• Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value

  2012cited by this paper
• Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study

  2012cited by this paper
• Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature

  2011cited by this paper
• Protein energy malnutrition predicts complications in liver cirrhosis

  2011cited by this paper
• Sarcopenia: European consensus on definition and diagnosis

  2010cited by this paper
• Incidence, Natural History, and Risk Factors of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt With Polytetrafluoroethylene-Covered Stent Grafts

  2008cited by this paper
• Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

  2004cited by this paper
• Polytetrafluoroethylene-Covered Stent Grafts for TIPS Procedure: 1-Year Patency and Clinical Results

  2004cited by this paper
• Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy.

  2003cited by this paper
• Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS

  2002cited by this paper
• Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography.

  1998cited by this paper
• ESPEN guidelines for nutrition in liver disease and transplantation.

  1997cited by this paper
• Does malnutrition affect survival in cirrhosis

  1996cited by this paper
• Does malnutrition affect survival in cirrhosis?

  1996cited by this paper
• Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi).

  1996cited by this paper
• Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors.

  1995cited by this paper
• Nutritional support in liver disease.

  1995cited by this paper

• Impact of quantitative dietary guidance on postoperative outcomes in patients undergoing transjugular intrahepatic portosystemic shunt surgery: a retrospective cohort study.

  2026cites this paper
• Outcomes after TIPS in patients with cirrhosis and sarcopenia: A systematic review and meta-analysis

  2025cites this paper
• Evidences and perspectives of transjugular intrahepatic portosystemic shunt: A bibliometric analysis from 1990 to 2024

  2025cites this paper
• Impact of Changes in Body Composition after Transjugular Intrahepatic Portosystemic Shunt Creation on Morbidity and Mortality: A Systematic Review.

  2025cites this paper
• Association between estimated total skeletal muscle mass and cognitive function in older adults.

  2025cites this paper
• A GLIM-defined malnutrition-based model for predicting prognosis of cirrhotic patients with portal hypertension following TIPS procedure

  2025cites this paper
• Plasma Ammonia Levels Predict Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement

  2025cites this paper
• Impact of Frailty on the Prognosis of Patients With Liver Cirrhosis Undergoing Insertion of a TIPS

  2025cites this paper
• Impact of Changes in Body Composition after Transjugular Intrahepatic Portosystemic Shunt Creation on Morbidity and Mortality: A Systematic Review.

  2025cites this paper
• Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation

  2025cites this paper
• Hepatic encephalopathy in cirrhosis: therapies and developments

  2025cites this paper
• Multiple Concomitant Precipitating Factors of Hepatic Encephalopathy Are Associated With a Poor Prognosis in Patients With Cirrhosis Admitted to Intensive Care Unit

  2025cites this paper
• Role of Nutrition in the Management of Chronic Liver Disease

  2025cites this paper
• TIPS and hepatic encephalopathy in patients with cirrhosis

  2025cites this paper
• The egg and the chicken: Does sarcopenia or cognitive impairment come first?

  2024cites this paper
• Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial

  2024cites this paper
• Sarcopenia in patients receiving TIPS is independently associated with increased risk of complications and mortality.

  2024cites this paper
• Bibliometric and visualized analysis of the correlation between sarcopenia and chronic liver diseases from 2000 to 2023

  2024cites this paper
• Sarcopenia in cirrhosis: From pathophysiology to interventional therapy.

  2024influential citation
• S2k-Leitlinie Klinische Ernährung in der Hepatologie

  2024cites this paper
• Food for the Brain: Is Vegan/Vegetarian Diet the Way to Go for Hepatic Encephalopathy?

  2024cites this paper
• Baseline and Longitudinal Body Composition Measurements Improve Prediction of Mortality and Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS) Placement.

  2024cites this paper
• Primary Prophylaxis of Overt Hepatic Encephalopathy: Is It Time to Consider It?

  2023cites this paper
• Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury

  2023cites this paper
• Improvement of sarcopenia is beneficial for prognosis in cirrhotic patients after TIPS placement.

  2023cites this paper
• Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution

  2023cites this paper
• Current Treatment Strategies and Future Possibilities for Sarcopenia in Cirrhosis.

  2023cites this paper
• The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review

  2023cites this paper
• Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease

  2023cites this paper
• Adipopenia in body composition analysis: a promising imaging biomarker and potential predictive factor for patients undergoing transjugular intrahepatic portosystemic shunt placement

  2023cites this paper
• Cirrhosis and Sarcopenia

  2023cites this paper
• Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt

  2023cites this paper
• Transjugular intrahepatic portosystemic shunt insertion improves muscle mass but not muscle function or frailty measures

  2023cites this paper
• Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt - TIPS, and strategies to improve the outcomes.

  2023influential citation
• Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis.

  2023cites this paper
• Association between sarcopenia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review and meta-analysis

  2023cites this paper
• Validating the prognostic value of muscle changes in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt

  2023cites this paper
• Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy

  2022influential citation
• Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis

  2022cites this paper
• Development and Validation of Prognostic Models to Estimate the Risk of Overt Hepatic Encephalopathy After TIPS Creation: A Multicenter Study

  2022cites this paper
• Post TIPS hepatic encephalopathy: Look at muscle and fat!

  2022cites this paper
• Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.

  2022cites this paper
• Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions

  2022cites this paper
• Management of Hepatic Encephalopathy Associated with Advanced Liver Disease

  2022cites this paper
• Pre-emptive TIPSS in Acute Variceal Bleeding: Current Status, Controversies, and Future Directions

  2022cites this paper
• Sarcopenia of Cirrhosis and the Therapeutic Potential of Transjugular Intrahepatic Portosystemic Shunt Creation

  2022cites this paper
• TIPS placement as the first-line therapy to prevent variceal rebleeding in patients with cirrhosis and sarcopenia.

  2022cites this paper
• Prevention of post-tips hepatic encephalopathy: The search of the ideal candidate

  2022cites this paper
• Albumin for cognitive impairment after TIPS: a road to be explored.

  2022cites this paper
• A comprehensive review of prognostic scoring systems to predict survival after transjugular intrahepatic portosystemic shunt placement

  2022cites this paper
• Determinants of prognosis in cirrhosis: a new outlook

  2022cites this paper
• Ammonia and prognosis of cirrhosis: a new perspective for identifying high risk patients.

  2022cites this paper
• The combination of Child–Pugh score and quantitative CT-based spleen volume could predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation

  2021cites this paper
• The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls

  2021cites this paper
• The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt

  2021cites this paper
• Treatment of Upper Gastrointestinal Bleeding by Percutaneous Transsplenic Varices Embolization in Chronic Hepatic Schistosomiasis Japonicum Patients.

  2021cites this paper
• Sarcopenia and frailty in decompensated cirrhosis.

  2021cites this paper
• Sarcopenia is poor risk for unfavorable short- and long-term outcomes in stage I non-small cell lung cancer

  2021cites this paper
• Management of Refractory Ascites Due to Portal Hypertension: Current Status.

  2021cites this paper
• Clinical impact of sarcopenia assessment in patients with liver cirrhosis

  2020influential citation
• Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy.

  2020cites this paper
• Review article: prognostic significance of body composition abnormalities in patients with cirrhosis

  2020cites this paper
• Efficacy of albumin-bilirubin score to predict hepatic encephalopathy in patients underwent transjugular intrahepatic portosystemic shunt.

  2020cites this paper
• Where does TIPS fit in the management of patients with cirrhosis?

  2020cites this paper
• High-mobility group protein B1: a predictive biomarker for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

  2020cites this paper
• Assessing skeletal muscle radiodensity by computed tomography: An integrative review of the applied methodologies

  2020influential citation
• Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.

  2020cites this paper
• Sarcopenia in chronic liver disease: easy to diagnose but hard to treat

  2020cites this paper
• Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation.

  2019cites this paper
• The value of different CT‐based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis

  2019cites this paper
• Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy

  2019cites this paper
• Sarcopenia in cirrhosis: from pathogenesis to interventions

  2019cites this paper
• Hepatic Encephalopathy and Nutrition Influences: A Narrative Review.

  2019cites this paper
• Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis

  2019cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper